| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.047 | 0.9 |